Treatment efficacy and tolerability of Sofosbuvir and Ribavirin for chronic hepatitis C infection in post renal transplant patients – A retrospective single centre study
Conclusion Sofosbuvir and ribavirin showed a good efficacy and tolerability when used in renal transplant recipients. However, the genotype, nature of underlying liver disease, duration of therapy play an important factor in deciding the response to therapy.
Source: Indian Journal of Transplantation - Category: Transplant Surgery Source Type: research
More News: Hepatitis | Hepatitis C | Liver | Liver Disease | Liver Transplant | Study | Transplant Surgery | Transplants | Urology & Nephrology | Virology